The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Adicet Bio, Inc. | COM | 007002108 | 4,198,717 | 728,944 | SH | DFND | 1 | 0 | 728,944 | 0 | ||
| Aldeyra Therapeutics, Inc. | COM | 01438T106 | 3,920,702 | 394,834 | SH | DFND | 1 | 0 | 394,834 | 0 | ||
| Apollomics, Inc. | CL A SHS | G0411D107 | 320,698 | 13,252 | SH | DFND | 1 | 0 | 13,252 | 0 | ||
| Arrowhead Pharmaceuticals, Inc. | COM | 04280A100 | 6,288,989 | 247,598 | SH | DFND | 1 | 0 | 247,598 | 0 | ||
| BiomX Inc. | COM | 09090D103 | 650,688 | 2,133,402 | SH | DFND | 1 | 0 | 2,133,402 | 0 | ||
| Catalyst Biosciences, Inc. | COM | 14888D208 | 13,859 | 66,951 | SH | DFND | 1 | 0 | 66,951 | 0 | ||
| Clearside Biomedical, Inc. | COM | 185063104 | 176,414 | 169,629 | SH | DFND | 1 | 0 | 169,629 | 0 | ||
| Cue Health, Inc. | COM | 229790100 | 10,098,932 | 5,548,864 | SH | DFND | 1 | 0 | 5,548,864 | 0 | ||
| CVRx, Inc. | COM | 126638105 | 32,578,759 | 3,495,575 | SH | DFND | 1 | 0 | 3,495,575 | 0 | ||
| Fate Therapeutics, Inc. | COM | 31189P102 | 19,260,665 | 3,379,064 | SH | DFND | 1 | 0 | 3,379,064 | 0 | ||
| Fusion Pharmaceuticals Inc. | COM | 36118A100 | 13,837,845 | 3,670,516 | SH | DFND | 1 | 0 | 3,670,516 | 0 | ||
| Legend Biotech Corporation | ADS | 52490G102 | 78,558,722 | 1,629,173 | SH | DFND | 1 | 0 | 1,629,173 | 0 | ||
| MeiraGTx Holdings plc | COM | G59665102 | 34,334,301 | 6,641,064 | SH | DFND | 1 | 0 | 6,641,064 | 0 | ||
| Nano-X Imaging Ltd. | ORD SHS | M70700105 | 1,833,152 | 317,704 | SH | DFND | 1 | 0 | 317,704 | 0 | ||
| Point Biopharma Global Inc. | COM | 730541109 | 7,270,000 | 1,000,000 | SH | DFND | 1 | 0 | 1,000,000 | 0 | ||
| Procept BioRobotics Corporation | COM | 74276L105 | 10,165,468 | 357,939 | SH | DFND | 1 | 0 | 357,939 | 0 | ||
| Protagonist Therapeutics Inc. | COM | 74366E102 | 56,331,209 | 2,449,183 | SH | DFND | 1 | 0 | 2,449,183 | 0 | ||
| Senseonics Holdings, Inc. | COM | 81727U105 | 38,781 | 54,621 | SH | DFND | 1 | 0 | 54,621 | 0 | ||
| Tracon Pharmaceuticals, Inc. | COM | 89237H209 | 158,766 | 84,003 | SH | DFND | 1 | 0 | 84,003 | 0 | ||
| VistaGen Therapeutics, Inc. | COM | 92840H202 | 23,755 | 190,494 | SH | DFND | 1 | 0 | 190,494 | 0 | ||
| Vor Biopharma, Inc. | COM | 929033108 | 5,781,660 | 1,074,658 | SH | DFND | 1 | 0 | 1,074,658 | 0 | ||
| Xencor, Inc. | COM | 98401F105 | 20,863,449 | 748,062 | SH | DFND | 1 | 0 | 748,062 | 0 | ||
| SomaLogic, Inc. | COM | 83444K105 | 716,683 | 281,052 | SH | DFND | 0 | 281,052 | 0 | |||